These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 15892665)

  • 1. Recent developments in the chemical biology of epothilones.
    Altmann KH
    Curr Pharm Des; 2005; 11(13):1595-613. PubMed ID: 15892665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epothilones as lead structures for new anticancer drugs--pharmacology, fermentation, and structure-activity-relationships.
    Altmann KH; Memmert K
    Prog Drug Res; 2008; 66():273, 275-334. PubMed ID: 18416309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The biology and medicinal chemistry of epothilones.
    Wartmann M; Altmann KH
    Curr Med Chem Anticancer Agents; 2002 Jan; 2(1):123-48. PubMed ID: 12678754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epothilone B and its analogs - a new family of anticancer agents.
    Altmann KH
    Mini Rev Med Chem; 2003 Mar; 3(2):149-58. PubMed ID: 12570848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis & antitumor activity of epothilones B and D and their analogs.
    Cheng H; Huang G
    Future Med Chem; 2018 Jun; 10(12):1483-1496. PubMed ID: 29788770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epothilones as lead structures for the synthesis-based discovery of new chemotypes for microtubule stabilization.
    Feyen F; Cachoux F; Gertsch J; Wartmann M; Altmann KH
    Acc Chem Res; 2008 Jan; 41(1):21-31. PubMed ID: 18159935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diversity through semisynthesis: the chemistry and biological activity of semisynthetic epothilone derivatives.
    Altmann KH; Gaugaz FZ; Schiess R
    Mol Divers; 2011 May; 15(2):383-99. PubMed ID: 21197573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A common pharmacophore for epothilone and taxanes: molecular basis for drug resistance conferred by tubulin mutations in human cancer cells.
    Giannakakou P; Gussio R; Nogales E; Downing KH; Zaharevitz D; Bollbuck B; Poy G; Sackett D; Nicolaou KC; Fojo T
    Proc Natl Acad Sci U S A; 2000 Mar; 97(6):2904-9. PubMed ID: 10688884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery and development of the epothilones : a novel class of antineoplastic drugs.
    Reichenbach H; Höfle G
    Drugs R D; 2008; 9(1):1-10. PubMed ID: 18095749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, anticancer activity and cytotoxicity of galactosylated epothilone B.
    Gao H; Huang G
    Bioorg Med Chem; 2018 Nov; 26(20):5578-5581. PubMed ID: 30318441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor efficacy of 26-fluoroepothilone B against human prostate cancer xenografts.
    Newman RA; Yang J; Raymond M; Finlay V; Cabral F; Vourloumis D; Stephens LC; Troncoso P; Wu X; Logothetis CJ; Nicolaou KC; Navone NM
    Cancer Chemother Pharmacol; 2001 Oct; 48(4):319-26. PubMed ID: 11710633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel tubulin-targeting agents: anticancer activity and pharmacologic profile of epothilones and related analogues.
    Fumoleau P; Coudert B; Isambert N; Ferrant E
    Ann Oncol; 2007 Jul; 18 Suppl 5():v9-15. PubMed ID: 17656562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preclinical discovery of ixabepilone, a highly active antineoplastic agent.
    Lee FY; Borzilleri R; Fairchild CR; Kamath A; Smykla R; Kramer R; Vite G
    Cancer Chemother Pharmacol; 2008 Dec; 63(1):157-66. PubMed ID: 18347795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epothilones as Natural Compounds for Novel Anticancer Drugs Development.
    Villegas C; González-Chavarría I; Burgos V; Iturra-Beiza H; Ulrich H; Paz C
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemical synthesis and biological properties of pyridine epothilones.
    Nicolaou KC; Scarpelli R; Bollbuck B; Werschkun B; Pereira MM; Wartmann M; Altmann KH; Zaharevitz D; Gussio R; Giannakakou P
    Chem Biol; 2000 Aug; 7(8):593-9. PubMed ID: 11048950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and antitumor activity of epothilone B.
    Cheng H; Huang H; Huang G
    Eur J Med Chem; 2018 Sep; 157():925-934. PubMed ID: 30149324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SAR and pH stability of cyano-substituted epothilones.
    Regueiro-Ren A; Leavitt K; Kim SH; Höfle G; Kiffe M; Gougoutas JZ; DiMarco JD; Lee FY; Fairchild CR; Long BH; Vite GD
    Org Lett; 2002 Oct; 4(22):3815-8. PubMed ID: 12599466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of novel epothilone analogs with cytotoxic activity by biotransformation.
    Tang L; Qiu RG; Li Y; Katz L
    J Antibiot (Tokyo); 2003 Jan; 56(1):16-23. PubMed ID: 12670045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis and biological evaluation of bridged epothilone D analogues.
    Chen QH; Ganesh T; Brodie P; Slebodnick C; Jiang Y; Banerjee A; Bane S; Snyder JP; Kingston DG
    Org Biomol Chem; 2008 Dec; 6(24):4542-52. PubMed ID: 19039362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3D QSAR models of interactions between beta-tubulin and microtubule stabilizing antimitotic agents (MSAA): a survey on taxanes and epothilones.
    Manetti F; Maccari L; Corelli F; Botta M
    Curr Top Med Chem; 2004; 4(2):203-17. PubMed ID: 14754454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.